Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.33, read 2026-11-02
Ethical does not pass the values gate
Price231.66 USD
Fair value286.00
Ethical score10.0/100
Value readUndervaluedas of 2 Nov 2026
Our investment reviews on this name
2026-10-29Read Accumulation224.46+3.2% to today ✓Markdown gives way to Accumulation after an 8% slide in 7 weeks
2026-09-09Read Markdown242.91-4.6% to today ✓Markup gives way to Markdown first Markdown read since July
2026-08-08Read Markup255.37-9.3% to today Markdown gives way to Markup after a 12% rise in 5 weeks
2026-07-02Read Markdown228.37+1.4% to today First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
PNC Financial Services holds its Accumulation at $231.66. The statistical read favours the buyers, held for 3 days.
As held on the ledger · 2026-11-02
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 3 days
Price at the screen
$231.66
Valuation
12.34 trailing · 10.86 forward price to earnings
Values screen
FAIL· score 10.0
Beta
0.93
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
PNC Financial Services does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-02. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PNC's ethical verdict changes
Today PNC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 2 Nov 2026: it trades at roughly a 20% discount to our $286.00 fair value, moderate competitive moat, 10.90% revenue growth.
Fair value range in USD, drawn from the 2026-11-02 screen. The gold marker is the market price at the same screen. A 19.0% discount to the base estimate.
Where our models see it going: fair-value estimate $286.00, with a range of $240.06 to $400.10, dated to the 2026-11-02 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Banks clear the books but fail the screen
Every month millions route salaries, mortgages and pensions through the same handful of regional banks. PNC sits among them, yet we pass. The numbers look orderly on the surface, yet the ethical screen blocks any further look.
Forward earnings sit at 11.9 times with revenue up 24 percent and a 31 percent profit margin. Return on equity reaches 13 percent and the moat is moderate. None of that matters once the business activity screen is failed. The market may still see a buy at a $279 median target, but we do not.
The real risk is simple: an ethical fail removes the stock from consideration regardless of valuation or growth. Margin of safety or not, the screen exists for exactly these cases. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PNC trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $263.
2026-10-22Markdown$214.94-1.9%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $264.
2026-10-15Markdown$219.21+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14Markdown$219.21+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-13Markdown$219.21+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-12Markdown$219.21-2.8%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Markdown$225.64+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-10Markdown$225.64+0.0%Entry 8
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (21 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-02Markdown$225.64-7.1%Entry 7
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $277.
2026-09-09Markdown · changed$242.91-4.9%Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 34%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (20 analysts) rates it buy, with a mean price target of $278.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
